Reply to Comment on: The Gabrin Sign

    November 2020 in “ Journal of The American Academy of Dermatology ”
    Carlos Gustavo Wambier, Sergio Vañó‐Galván, Andy Goren
    Image of study
    TLDR Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.
    The authors of the document respond to a comment on their work regarding the "Gabrin sign," which is an observation that males and individuals with androgenetic alopecia (AGA) may be more vulnerable to severe COVID-19. They discuss the potential role of androgens in COVID-19 severity and the protective effects of anti-androgens. They cite studies that support the association between severe AGA and COVID-19 vulnerability, including a study examining hair loss severity in 1,941 hospitalized COVID-19 patients and a controlled cross-sectional survey with 43,595 participants. They also mention a prospective cohort of 77 hospitalized men showing that anti-androgens may protect against severe COVID-19 outcomes. The authors highlight ongoing clinical trials evaluating anti-androgen therapies for COVID-19 and emphasize the importance of recognizing AGA as a potential visual marker for significant COVID-19 disease burden in medical emergency settings. They conclude by honoring Dr. Gabrin, the first physician to die from COVID-19 in the United States, whose name is associated with the medical eponym "Gabrin sign."
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 1000+ results

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  136 upvotes 7 months ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

      community For those on TRT and suffer from a more aggressive type of (AGA) hairloss, what are your hair safe protocols?

      in Chat  6 upvotes 1 year ago
      People on testosterone replacement therapy (TRT) with aggressive androgenetic alopecia (AGA) discuss using Dutasteride or Finasteride, sometimes combined with topical treatments like RU58841 or CB-03-01 (Breezula), to prevent hair loss. Concerns about side effects and costs of certain treatments are mentioned, with one individual sharing their experience of slowed hair loss using Finasteride alone.

      community Homemade topical spironolactone

      in Research/Science  26 upvotes 2 years ago
      The potential effectiveness of homemade topical spironolactone in treating hair loss, with studies suggesting it is more effective than finasteride and even minoxidil when used as monotherapy. The conversation also mentions that other anti-androgens are being developed which may soon hit the market.

      community Received Kintor’s KX-826 Today

      in Product  84 upvotes 3 months ago
      A user received Kintor’s KX-826/Pyrilutamide and shared initial impressions, noting concerns about the product's labeling and marketing. Other users discussed the legitimacy of the product, its effectiveness, and compared it to other treatments like Minoxidil and Finasteride.

    Similar Research

    6 / 1000+ results